Prevalence of Human T-Cell Lymphotropic Virus (HTLV-1/2) in Individuals from Public Health Centers in Mozambique

Abstract

The prevalence of human T-cell lymphotropic viruses types 1 and 2 (HTLV-1/2) in Mozambique is not known. The present study examined blood samples from 208, 226, and 318 individuals from Northern, Central, and Southern Mozambique, respectively, of all socioeconomic and demographic strata attending public health centers in Mozambique for HTLV-1/2–specific antibodies. Serum samples were assessed for HIV- and HTLV-1/2–specific antibodies by using enzyme immunoassays, and infections with HTLV-1 and -2 were confirmed by using Western blot. An overall HTLV-1/2 prevalence of 2.3% (2.9% in female and 1.1% in male subjects) was observed, and the prevalence of infection increased with age. Regional variation in the prevalence of HIV and HTLV-1/2 was observed; 32.2%, 65.5%, and 44% of individuals tested HIV positive in Northern, Central, and Southern Mozambique, respectively, and 2.4%, 3.9%, and 0.9% tested HTLV-1/2 positive in the same regions. HTLV-1 infection was confirmed in these individuals. No association between HTLV-1 infection and sociodemographic variables or HIV status was detected, although the low number of HTLV-1–positive cases did not allow robust statistical analyses. The results obtained suggest different risk factors and epidemiologic correlates of HIV and HTLV-1 transmission in Mozambique. Furthermore, our results suggested that North and Central Mozambique should be considered endemic regions for HTLV-1 infection. As no cases of HTLV-2 were detected, HTLV-2 appears to have not been introduced into Mozambique.

Get full access to this article

View all access options for this article.

References

Taylor

, Bodéus

, Courtois

et al. The seroepidemiology of human T-lymphotropic viruses types I and II in Europe: a prospective study of pregnant women. J Acquir Immune Defic Syndr, 2005; 38:104–109.

Van Rensburg

, Lemmer

, Joubert

. Prevalence of viral infections in Mozambican refugees in Swaziland. East Afr Med J, 1995; 72:588–590.

Engelbrecht

, Koulinska

, Smith

T-L

et al. Subtyping of human T cell lymphotropic virus type I from tropical spastic paraparesis/HTLV-associated myelopathy patients in Mozambique. AIDS Res Hum Retroviruses, 1999; 15:71–72.

Melo

, Beby-Dcfaux

, Faria

et al. HIV and HTLV prevalences among women seen for sexually transmitted diseases or pregnancy follow-up in Maputo, Mozambique. J Acquir Immune Defic Syndr, 2000; 23:203–204.

Cunha

, Plouzeau

, Ingrand

et al. Use of replacement blood donors to study the epidemiology of major blood-borne viruses in the general population of Maputo, Mozambique. J Med Virol, 2007; 79:1832–1840.

Gudo

, Abreu

, Mussá

et al. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo city, Mozambique. Transfusion, 2009; 49:1146–1150.

Proietti

, Carneiro-Proietti

ABF

, Catalan-Soares

et al. Global epidemiology of HTLV-I infection and associated diseases. Oncogene, 2005; 24:6058–6068.

Murphy

, Watanabe

, Nass

et al. for the Retrovirus Epidemiology Donors Study. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States. J Infect Dis, 1999; 180:1777–1783.

Caterino-de-Araujo

, Manuel

RCR

, Del Bianco

et al. Seroprevalence of human herpesvirus 8 (HHV-8) infection in individuals from health care centers in Mozambique: potential for endemic, epidemic Kaposi's sarcoma. J Med Virol(in press).